Join Sona Nanotech’s CEO David Regan and CSO Len Pagliaro for a live webinar on which they will discuss the progress of Sona’s pre-clinical cancer Targeted Hyperthermia Therapy, which leverages Sona’s biocompatible Gold Nanorods.
This is a great opportunity to learn more about Sona’s proprietary technology and recently announced equity financing.
The session will end with a Q&A, so bring your questions and get them answered by David and Len.